Goldman Sachs’s American Renal Associates Holdings, Inc ARA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-101,423
| Closed | -$1.16M | – | 5530 |
|
|
2020
Q4 | $1.16M | Buy |
101,423
+75,243
| +287% | +$861K | ﹤0.01% | 3371 |
|
|
2020
Q3 | $181K | Buy |
26,180
+1,477
| +6% | +$10.2K | ﹤0.01% | 4097 |
|
|
2020
Q2 | $161K | Sell |
24,703
-14,230
| -37% | -$92.7K | ﹤0.01% | 4059 |
|
|
2020
Q1 | $257K | Sell |
38,933
-5,641
| -13% | -$37.2K | ﹤0.01% | 3840 |
|
|
2019
Q4 | $462K | Sell |
44,574
-3,010
| -6% | -$31.2K | ﹤0.01% | 3688 |
|
|
2019
Q3 | $301K | Sell |
47,584
-24,911
| -34% | -$158K | ﹤0.01% | 3789 |
|
|
2019
Q2 | $539K | Buy |
72,495
+57,517
| +384% | +$428K | ﹤0.01% | 3502 |
|
|
2019
Q1 | $92K | Sell |
14,978
-12,233
| -45% | -$75.1K | ﹤0.01% | 4025 |
|
|
2018
Q4 | $313K | Sell |
27,211
-3,514
| -11% | -$40.4K | ﹤0.01% | 3583 |
|
|
2018
Q3 | $665K | Buy |
30,725
+3,670
| +14% | +$79.4K | ﹤0.01% | 3343 |
|
|
2018
Q2 | $427K | Buy |
27,055
+12,085
| +81% | +$191K | ﹤0.01% | 3600 |
|
|
2018
Q1 | $282K | Buy |
14,970
+1,288
| +9% | +$24.3K | ﹤0.01% | 3723 |
|
|
2017
Q4 | $238K | Sell |
13,682
-659,832
| -98% | -$11.5M | ﹤0.01% | 3756 |
|
|
2017
Q3 | $10.1M | Sell |
673,514
-27,630
| -4% | -$414K | ﹤0.01% | 1967 |
|
|
2017
Q2 | $13M | Sell |
701,144
-8,063
| -1% | -$150K | ﹤0.01% | 1793 |
|
|
2017
Q1 | $12M | Sell |
709,207
-3,201
| -0.4% | -$54K | ﹤0.01% | 1764 |
|
|
2016
Q4 | $15.2M | Sell |
712,408
-30,756
| -4% | -$654K | ﹤0.01% | 1623 |
|
|
2016
Q3 | $13.6M | Buy |
743,164
+235,608
| +46% | +$4.3M | ﹤0.01% | 1679 |
|
|
2016
Q2 | $14.7M | Buy |
+507,556
| New | +$14.7M | ﹤0.01% | 1559 |
|